These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11848295)

  • 1. Neurotensin analogs indications for use as potential antipsychotic compounds.
    McMahon BM; Boules M; Warrington L; Richelson E
    Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin receptor agonists and antagonists for schizophrenia.
    Richelson E; Fredrickson PA; Boules MM
    Am J Psychiatry; 2005 Mar; 162(3):633-4; author reply 635. PubMed ID: 15741499
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotensin: peptide for the next millennium.
    Tyler-McMahon BM; Boules M; Richelson E
    Regul Pept; 2000 Sep; 93(1-3):125-36. PubMed ID: 11033059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin agonists as an alternative to antipsychotics.
    Boules M; Fredrickson P; Richelson E
    Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor agonists and antagonists for schizophrenia.
    Robertson VB; Wilson MS
    Am J Psychiatry; 2005 Mar; 162(3):634; author reply 635. PubMed ID: 15741502
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
    Griebel G
    Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel treatments of schizophrenia: targeting the neurotensin system.
    Kinkead B; Nemeroff CB
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
    Kinkead B; Nemeroff CB
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin: an endogenous antipsychotic?
    Kinkead B; Nemeroff CB
    Curr Opin Pharmacol; 2002 Feb; 2(1):99-103. PubMed ID: 11786316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin agonists: potential in the treatment of schizophrenia.
    Boules M; Shaw A; Fredrickson P; Richelson E
    CNS Drugs; 2007; 21(1):13-23. PubMed ID: 17190526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
    Richelson E; Boules M; Fredrickson P
    Life Sci; 2003 Jun; 73(6):679-90. PubMed ID: 12801589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurotensin--structure, origin and biological function].
    Kulińska-Niedziela I; Paluszak J
    Postepy Hig Med Dosw; 1997; 51(3):329-42. PubMed ID: 9333784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.
    Lazarova M; Popatanasov A; Klissurov R; Stoeva S; Pajpanova T; Kalfin R; Tancheva L
    J Mol Neurosci; 2018 Dec; 66(4):552-560. PubMed ID: 30374780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
    Sharma RP; Janicak PG; Bissette G; Nemeroff CB
    Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin and neurotensin receptors.
    Vincent JP; Mazella J; Kitabgi P
    Trends Pharmacol Sci; 1999 Jul; 20(7):302-9. PubMed ID: 10390649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
    Vadnie CA; Ayers-Ringler J; Oliveros A; Abulseoud OA; Choi S; Hitschfeld MJ; Choi DS
    Behav Brain Res; 2016 May; 305():8-17. PubMed ID: 26909848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.